These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10582682)

  • 41. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
    Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
    Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
    Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
    Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BCL10 down-regulation in peripheral T-cell lymphomas.
    Rossi M; Agostinelli C; Righi S; Sabattini E; Bacci F; Gazzola A; Pileri SA; Piccaluga PP
    Hum Pathol; 2012 Dec; 43(12):2266-73. PubMed ID: 22818167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of Bcl10 gene mutations in Ewing's sarcomas.
    Park YK; Chi SG; Unni KK
    Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcl10 mutations in malignancy.
    Dyer MJ
    Br J Cancer; 1999 Jul; 80(10):1491. PubMed ID: 10408386
    [No Abstract]   [Full Text] [Related]  

  • 49. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
    Tadokoro J; Nakamura Y; Furusawa S; Mitani K
    Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.
    Re D; Benenson E; Wolf J; Diehl V; Staratschek-Jox A
    Br J Haematol; 2000 May; 109(2):420-2. PubMed ID: 10848834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BCL10 expression is unrelated to clinico-pathological parameters or prognoses for oral squamous cell carcinomas.
    Moar-Antelo AR; Pérez-Sayáns M; Suárez-Peñaranda JM; Gayoso-Diz P; Barros-Angueira F; Gándara-Rey JM; García-García A
    Biotech Histochem; 2012 Aug; 87(6):423-7. PubMed ID: 22734454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCL10 mutations are irrelevant to its aberrant nuclear localization in nasal NK/T-cell lymphoma.
    Shen L; Liang AC; Au WY; Lu L; Chen YW; Wong KY; Tang JC; Chan KW; Beh SL; Kwong YL; Liang RH; Srivastava G
    Leukemia; 2003 Nov; 17(11):2240-2. PubMed ID: 14523480
    [No Abstract]   [Full Text] [Related]  

  • 53. Aggressive mucosa associated lymphoid tissue lymphomas are associated with mutations in Bcl10.
    Spencer J
    Gut; 1999 Jun; 44(6):778-9. PubMed ID: 10323877
    [No Abstract]   [Full Text] [Related]  

  • 54. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
    Yuille MR; Stone JG; Bradshaw PS; Houlston RS
    Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BCL10 deletions in haematological malignancies: a cloning artefact?
    Duke V; Kapoor A; Gricks C; Melo J; Foroni L
    Br J Haematol; 2000 Dec; 111(4):1106-8. PubMed ID: 11167747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bcl10.
    Thome M; Tschopp J
    Curr Biol; 2002 Jan; 12(2):R45. PubMed ID: 11818074
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of BCL10 mutations in human malignant mesothelioma.
    Apostolou S; De Rienzo A; Murthy SS; Jhanwar SC; Testa JR
    Cell; 1999 Jun; 97(6):684-6; discussion 686-8. PubMed ID: 10380921
    [No Abstract]   [Full Text] [Related]  

  • 58. Chromosome 7q deletions: observations on 13 malignant tumors.
    Atkin NB; Baker MC
    Cancer Genet Cytogenet; 1993 Jun; 67(2):123-5. PubMed ID: 8330268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No evidence for deletions of the NBS1 gene in lymphomas.
    Stumm M; von Ruskowsky A; Siebert R; Harder S; Varon R; Wieacker P; Schlegelberger B
    Cancer Genet Cytogenet; 2001 Apr; 126(1):60-2. PubMed ID: 11343781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatic mutations of CASP3 gene in human cancers.
    Soung YH; Lee JW; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Hum Genet; 2004 Jul; 115(2):112-5. PubMed ID: 15127291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.